Home
Rhinomed Limited
ASX Code
RNO
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.rhinomed.global/investor-information/
Website
https://www.rhinomed.global/
About
Rhinomed is an airway technology company that seeks to radically improve the way you breathe, sleep, maintain your health and take medication.
Rhinomed’s patented nasal technology leverages the physiology of the nose to optimise our breathing which is essential to restful sleep and to maintaining good health.
Rhinomed’s vision for the future is to enable medications to be administered through the nose with the aim of improving the efficiency and effectiveness of the therapies, while seeking a reduction in side effects for patients.
Rhinomed continues to invest in furthering our knowledge of the role the nose, the upper airways and the olfactory system plays in maintaining health and wellness. Rhinomed’s technology platform is protected by a family of over 60 patents globally.